Caroline Lavoie
Centre hospitalier universitaire de Québec, Université de Sherbrooke
Papers
3
Total Citations
88
H-Index
3
About
Dr. Caroline Lavoie is a leading radiation oncologist whose research bridges the frontiers of stereotactic ablative radiotherapy (SABR) and patient-centered outcomes in oncology. Her seminal 2014 study on patient-adapted robotic lung SBRT (33 citations) established that CyberKnife-based treatment yields excellent cancer control for early-stage non-small cell lung cancer, while issuing a critical caution for idiopathic pulmonary fibrosis patients—a finding that directly shaped clinical guidelines. Complementing this, her 2015 investigation into long-term quality of life (24 citations) demonstrated that robotic SABR preserves functional well-being, challenging assumptions about radiation toxicity. Demonstrating remarkable interdisciplinary breadth, Dr. Lavoie also pioneered the Virtual Peg Insertion Test as a novel assessment of upper limb coordination in ARSACS patients (31 citations), expanding her impact beyond oncology into neurodegenerative disease. Her work is defined by a dual commitment: optimizing tumor control through technical innovation while rigorously measuring what matters most to patients—survival, safety, and quality of life. For students and researchers, Dr. Lavoie exemplifies how translational research can simultaneously advance precision radiotherapy and deepen our understanding of patient experience.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3